Tilray Brands Announces Enhancements to Accretive Strategic Transaction with HEXO
Amended Terms Include Increased Discount on Purchase Price of HEXO Note and Reduced Tilray Conversion Price on HEXO Shares Reaffirms...
News
aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment
Poster to be presented at the Keystone Symposia on Tissue Fibrosis and Repair. Second tRNA synthetase receptor identified from company’s...
UpHealth Announces the Removal of Dr. Chirinjeev Kathuria as Co-Chairman of the Board of Directors
Action Taken to Ensure Orderly Functioning of the Board Dr. Avi Katz to Serve as Sole Independent Chairman DELRAY BEACH,...
OrthoPediatrics Corp. Announces Deal to Acquire Pega Medical
Expands portfolio of trauma and deformity systems for pediatric orthopedics, including the Fassier-Duval Telescopic IM System™WARSAW, Ind., June 14, 2022...
Hepion Pharmaceuticals Appoints Accomplished Life Sciences Industry Veteran, Dr. Launa J. Aspeslet, as Chief Operating Officer
- Dr. Aspeslet joins the Company to support rencofilstat’s clinical program - EDISON, N.J., June 14, 2022 (GLOBE NEWSWIRE) --...
Acasti Pharma Announces the Issuance of Additional Patents for GTX-104 and GTX-101
LAVAL, Québec, June 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST),...
EDAP holds a Symposium at 6th European Endometriosis Congress
LYON, France, June 14, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies,...
Origin Therapeutics Applauds Incoming Decriminalization for Potential to Reduce Stigma
Vancouver, B.C., June 14, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”), an actively...
NEW Opioids Overdose Response Training to Empower High School Students to Help Save Lives
ACT High School Opioid Overdose Response Training Empowering high school teachers to add theOpioid Overdose Response Training to theirstudents’ lifesaving...
InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions
VANCOUVER, British Columbia, June 14, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader...
Presentations at ASM Microbe Conference Demonstrate Potential of ContraFect’s Direct Lytic Agents (DLAs) to Address MRSA Infections
YONKERS, N.Y., June 14, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the...
Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting Firm
FORT COLLINS, Colo., June 14, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a...
Vyluma and Laboratoires Théa Enter into Licensing Agreement for the Registration and Commercialization of NVK002 in Canada, Mexico, and Select South American Countries
BRIDGEWATER, N.J., June 14, 2022 (GLOBE NEWSWIRE) -- Vyluma, Inc. (“Vyluma”), a biopharmaceutical company developing multiple assets in the ophthalmic...
Day One Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a clinical-stage biopharmaceutical company...
Spectral and Dialco Announce Dr. John Kellum to be Featured as Keynote Lecturer at the 40th Vicenza Course on AKI and CRRT 2022
Dr. Kellum Invited to Participate on Additional Featured PanelsTORONTO, June 14, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or...
The Biogen Foundation and Community Lab Celebrates 20 Years of Serving our Communities
The Biogen Foundation has granted $70 million to help underserved communities in advancing science education, health equity, and food securityMore...
Clearside Biomedical Expands Leadership Team with Appointment of Susan Coultas, Ph.D., as Chief Clinical Officer
- Seasoned Life Science Executive Brings Expertise in Ophthalmic Clinical Development, Including Advancement of Multiple Late-Stage Programs to Product Approval...
Trevena Announces the Publication of an Expert Review on the Clinical Profile of OLINVYK® in Post-Operative Care
CHESTERBROOK, Pa., June 14, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and...
Freeline Initiates Dosing of Second Cohort in B-LIEVE Dose Confirmation Trial of FLT180a in Hemophilia B
Initial cohort one data suggest predictable and sustained Factor IX normalization, supporting additional dosing at the same low dose with...
Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results
NEW YORK and DURHAM, N.C., June 14, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX) today provided financial...